NDRA ENDRA Life Sciences Inc.

NASDAQ
$3.58

ENDRA Life Sciences Inc. (NDRA) is expected to report earnings on February 15, 2027, after the market close. The consensus earnings estimate is a loss of $0.84 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -18.9% since its last earnings release on November 16, 2026.

ENDRA Life Sciences Beat Consensus Estimates
Monday, November 16, 2026 · 4:44 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 15
Monday · After Close
Earnings Whisper
-
vs ($0.84)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $3.80

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.